Prosecution Insights
Last updated: August 18, 2026

University of Massachusetts

64 pending office actions • 35 art units • 58 examiners • 0 of 64 (0%) have an AI response strategy ready • 86 patents granted in the last 365 days

Portfolio Summary

64
Total Pending OAs
41
Non-Final OAs
20
Final Rejections
3
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 24 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

14
Overdue
0
Due this week
6
Due this month
4
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 24 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (14)Due ≤ 30 days (6)Due ≤ 60 days (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

26
Hard (41%)
28
Medium (44%)
10
Easy (16%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other4 (6%)
§103 only19 (30%)
§102 only2 (3%)
§112 only7 (11%)
Double-patenting only3 (5%)
Double-patenting + other7 (11%)
Multi-statute (no §101)22 (34%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

43
Life Sciences
67% of docket
1
Information Tech
2% of docket
1
Communications
2% of docket
2
Semiconductors
3% of docket
8
Mechanical / Eng
12% of docket
9
Business / Other
14% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

640 h
Manual time on pending OAs
128 h
Time saved (low, 20%)
224 h
Time saved (mid, 35%)
5.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LEONARD, ARTHUR S 3 50.9% +50.5%
GROOMS, TIFFANY NICOLE 3 58.8% +46.8%
KONOPKA, CATHERINE ANNE 2 58.2% +64.5%
ARIETI, RUTH SOPHIA 2 45.3% +72.1%
VANHORN, ABIGAIL LOUISE 1 47.0% +22.0%
SALVOZA, M FRANCO G 1 68.7% +29.6%
NAH, JONGBONG 1 76.3% +16.3%
KRASNOW, NICHOLAS R 1 66.5% +12.5%
MUTCHLER, CHRISTOPHER JOHN 1 55.4% +22.2%
VONCH, JEFFREY A 1 52.1% +44.0%

Hard Cases (26)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18247157 MARF/MFN MODULATORS AND USES THEREOF GROOMS, TIFFANY NICOLE 37d overdue
16762003 Post-Operative Hybrid Dressing To Optimize Skin-Grafting Procedures In Reconstructive Surgery HAN, SETH 28d overdue
18688729 AMPLIFIABLE METABOLIC LABELING FOR DETECTION OF BACTERIAL VIABILITY, GROWTH AND ANTIBIOTIC SUSCEPTIBILITY FAN, WEIHUA 18d overdue
18217073 ALIGNMENT KEY INCLUDING MULTI-FOCAL META-LENS AND ALIGNMENT APPARATUS INCLUDING THE ALIGNMENT KEY DEAN, RAY ALEXANDER 9d overdue
17777363 COMPOSITIONS AND METHODS FOR OPTOGENETIC IMMUNOTHERAPY SUNSHINE, HANNAH LOUISE 5d overdue
18278260 INDUCIBLE SINGLE AAV SYSTEM AND USES THEREOF ZAHORIK, AMANDA MARY 1d overdue
18081604 NANODEVICES AND METHODS FOR MEASURING BIOFLUIDIC FLOW USING A GRAPHENE-BASED MICROELECTRODE MONTGOMERY, MELISSA JO 9d
18134167 OLIGONUCLEOTIDES FOR ATN1 MODULATION MCLEOD, AFRICA MHAIRIE 26d

Interview Candidates (16)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18980456 Targeted CRISPR Delivery Platforms LEONARD, ARTHUR S 50d overdue
18247157 MARF/MFN MODULATORS AND USES THEREOF GROOMS, TIFFANY NICOLE 37d overdue
17921027 IMPROVED CAS 12A/NLS MEDIATED THERAPEUTIC GENE EDITING PLATFORMS KONOPKA, CATHERINE ANNE 16d overdue
18049724 COMPLEXES FOR GENE DELETION AND EDITING LEONARD, ARTHUR S 11d overdue
17532636 OLIGONUCLEOTIDES FOR DGAT2 MODULATION ARIETI, RUTH SOPHIA 2d overdue
19217607 VECTOR-BASED GENE THERAPY FOR ELONGATOR ACETYLTRANSFERASE COMPLEX SUBUNIT 1 (ELP1) SALVOZA, M FRANCO G 57d
19568680 YEAST CELL WALL PARTICLE ENCAPSULATION OF BIODEGRADABLE PRO-PAYLOADS VANHORN, ABIGAIL LOUISE
18869129 METHODS AND SYSTEMS FOR IMAGING INTERACTIONS BETWEEN PARTICLES AND FRAGMENTS NAH, JONGBONG

Top Art Units

Art UnitApps
1635 7
1637 7
1636 4
1631 2
1762 2
2872 2
1633 2
1675 2
1672 1
1744 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19568680 YEAST CELL WALL PARTICLE ENCAPSULATION OF BIODEGRADABLE PRO-PAYLOADS VANHORN, ABIGAIL LOUISE 1636 DP Non-Final OA Pending Mar 16, 2026
19217607 VECTOR-BASED GENE THERAPY FOR ELONGATOR ACETYLTRANSFERASE COMPLEX SUBUNIT 1 (ELP1) SALVOZA, M FRANCO G 1672 §112 Non-Final OA 57d Pending May 23, 2025
18980456 Targeted CRISPR Delivery Platforms LEONARD, ARTHUR S 1631 DP Non-Final OA 50d overdue Pending Dec 13, 2024
18869129 METHODS AND SYSTEMS FOR IMAGING INTERACTIONS BETWEEN PARTICLES AND FRAGMENTS NAH, JONGBONG §103 Non-Final OA Pending Nov 25, 2024
18942155 THERMAL IMPRINTING OF NANOSTRUCTURE MATERIALS KRASNOW, NICHOLAS R 1744 §102 Non-Final OA Pending Nov 08, 2024
18908922 OPTICAL NEURAL PROBE WITH DUAL COLOR LED MUTCHLER, CHRISTOPHER JOHN §103 Non-Final OA Pending Oct 08, 2024
18807414 PATTERNING OF COMPLEX METAL OXIDE STRUCTURES VONCH, JEFFREY A §102§103 Non-Final OA Pending Aug 16, 2024
18746105 MODIFIED AAV CONSTRUCTS AND USES THEREOF BRETZ, COREY LANE 1635 §112DP Non-Final OA Pending Jun 18, 2024
18719340 CONSTITUTIVE PRODUCTION OF MICROCINS TO TARGET ENTERIC BACTERIA RIGA, MICHAEL ANGELO §103 Non-Final OA Pending Jun 13, 2024
18671475 ARTICLE COMPRISING NON-WELDABLE SUPERALLOYS AND METHODS OF MANUFACTURE THEREOF SULTANA, NAHIDA 1785 §112 Non-Final OA Pending May 22, 2024
18660623 INTRAVENOUS POLE FOR IMPROVED SAFETY AND ACCURACY OF INTRAVENOUS MEDICATION ADMINISTRATION SOLOMON, JOSHUA BRENDON 3792 §103 Final Rejection Pending May 10, 2024
18706551 USES OF RHODOQUINONE FOR THE TREATMENT OF DISEASE BRAUN, MADELINE E §102§103§112 Non-Final OA Pending May 01, 2024
18702777 METHOD OF FORMING GRAPHENE FILMS MCCRACKEN, DANIEL 1736 §103 Final Rejection Pending Apr 18, 2024
18611933 ORAL ROOM-TEMPERATURE STABLE YEAST PARTICLES (YP) AND METHODS OF USE COHEN, MICHAEL P 1612 §103§112 Non-Final OA Pending Mar 21, 2024
18612111 Targeted CRISPR Delivery Platforms LEONARD, ARTHUR S DP Non-Final OA Pending Mar 21, 2024
18688729 AMPLIFIABLE METABOLIC LABELING FOR DETECTION OF BACTERIAL VIABILITY, GROWTH AND ANTIBIOTIC SUSCEPTIBILITY FAN, WEIHUA 1663 §102§103§112 Non-Final OA 18d overdue Pending Mar 01, 2024
18582916 COMPACT MICRORING SCHEME FOR CHIP LASER INJECTION LOCKING AND OPTICAL PARAMETRIC OSCILLATION LEUNG, CHRISTINA Y §112 Non-Final OA Pending Feb 21, 2024
18439034 STABILIZATION OF OLIGONUCLEOTIDE AND OLIGONUCLEOTIDE-PROTEIN COMPLEX USING ALKYLATED PHOSPHATE MCINTOSH III, TRAVISS C §102 Non-Final OA Pending Feb 12, 2024
18577623 MODULAR PRIME EDITING SYSTEMS FOR GENOME ENGINEERING WARD, AARON DUREL §102§112 Non-Final OA Pending Jan 08, 2024
18566367 CAS9 NICKASE-MEDIATED GENE EDITING NICOL, ALEXANDER W 1634 §102§103 Non-Final OA 34d Pending Dec 01, 2023
18288786 ERGONOMIC SURGICAL INSTRUMENTS MENDEZ, KATHERINE H 3771 §102§103§112 Non-Final OA Pending Oct 27, 2023
18482052 NANOPORE TWEEZER APPROACH FOR PROTEIN KINASE ALLOSTERIC DRUG SCREENING MCKNIGHT, CIARA A 1656 §102§112 Non-Final OA Pending Oct 06, 2023
18375235 OLIGONUCLEOTIDES TARGETING S6K1 YU, DELPHINUS DOU YI 1636 §103DP Non-Final OA Pending Sep 29, 2023
18553357 Specific Oligonucleotide-Programmed Readthrough of Nonsense Codons KONOPKA, CATHERINE ANNE 1635 §101§102§112 Non-Final OA Pending Sep 29, 2023
18283201 PRIME EDITING-BASED SIMULTANEOUS GENOMIC DELETION AND INSERTION ALLEN, SARAH ELIZABETH 1637 §103§112 Non-Final OA Pending Sep 20, 2023
18279931 PHOTOCAGED CITRULLINE ANALOGS AND METHODS FOR SITE-SPECIFIC INCORPORATION OF CITRULLINE INTO PROTEINS REYNOLDS, FRED H 1658 §102§103 Non-Final OA 57d Pending Sep 01, 2023
18278260 INDUCIBLE SINGLE AAV SYSTEM AND USES THEREOF ZAHORIK, AMANDA MARY 1636 §102§103§112 Non-Final OA 1d overdue Pending Aug 22, 2023
18278338 GENOME EDITING FOR TREATING MUSCULAR DYSTROPHY POLIAKOVA-GEORGAN, EKATERINA 1637 §102§103§112DP Non-Final OA Pending Aug 22, 2023
18233077 PROTEIN-POLYMER NANOASSEMBLIES AND INTRACELLULAR PROTEIN DELIVERY YOON, TAE H 1762 §103 Final Rejection 3d overdue Pending Aug 11, 2023
18227569 DISPERSION AND COATINGS DERIVED THEREFROM BLEDSOE, JOSHUA CALEB 1762 §103 Non-Final OA 19d Pending Jul 28, 2023
18226834 YEAST PARTICLES FOR DELIVERY OF WATER-ACTIVATED SELF-EMULSIFYING CANNABINOID FORMULATIONS SCOTLAND, REBECCA LYNN 1791 §102§103§112DP Non-Final OA Pending Jul 27, 2023
18217073 ALIGNMENT KEY INCLUDING MULTI-FOCAL META-LENS AND ALIGNMENT APPARATUS INCLUDING THE ALIGNMENT KEY DEAN, RAY ALEXANDER 2872 §102§103 Non-Final OA 9d overdue Pending Jun 30, 2023
18255661 SYSTEM AND METHOD FOR HYDRODYNAMIC CULTIVATION OF SEED OXYGENIC PHOTOGRANULES VARMA, AKASH K 1773 §103 Final Rejection Pending Jun 02, 2023
18326502 MOBILE FLOATING OFFSHORE WIND ENERGY SYSTEM BURGESS, MARC R 3615 §102§103 Final Rejection Pending May 31, 2023
18324540 PLUSH TOY WITH ARRAY OF TEXTILE-BASED SENSORS FOR INTERACTION DETECTION LIM, SENG HENG 3715 §103 Final Rejection Pending May 26, 2023
18197948 OPTIMIZED SIRNA SCAFFOLDS GROOMS, TIFFANY NICOLE 1637 §102§103§112DP Non-Final OA Pending May 16, 2023
18140908 SELECTIVE RNA-MODULATING AGENTS GROOMS, TIFFANY NICOLE 1637 §103§112DP Non-Final OA Pending Apr 28, 2023
18141166 PROTECTING OLIGONUCLEOTIDES FOR CRISPR GUIDE RNA MEYERING, SHABANA SHABBEER 1635 §102§103§112 Non-Final OA Pending Apr 28, 2023
18304472 GENE THERAPEUTICS FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA MOORE, JOHN DAVID 1638 §103 Final Rejection 98d overdue Pending Apr 21, 2023
18299947 REDOX FLOW BATTERY AKRAM, IMRAN 1725 §102§103§112Other Non-Final OA Pending Apr 13, 2023
18134167 OLIGONUCLEOTIDES FOR ATN1 MODULATION MCLEOD, AFRICA MHAIRIE 1635 §101§102§103§112 Non-Final OA 26d Pending Apr 13, 2023
18247157 MARF/MFN MODULATORS AND USES THEREOF GROOMS, TIFFANY NICOLE 1637 §103§112 Final Rejection 37d overdue Pending Mar 29, 2023
18088544 POLYMERIC NANOPARTICLES AND DERIVATIVES THEREOF FOR NUCLEIC ACID BINDING AND DELIVERY POPA, ILEANA 1633 §103Other Final Rejection 28d Pending Dec 24, 2022
18081604 NANODEVICES AND METHODS FOR MEASURING BIOFLUIDIC FLOW USING A GRAPHENE-BASED MICROELECTRODE MONTGOMERY, MELISSA JO 3791 §102§103§112 Non-Final OA 9d Pending Dec 14, 2022
17927642 Gasdermin D (GSDMD) Succination for the Treatment of Inflammatory Disease HAVLIN, ROBERT H 1626 §102§103 Final Rejection 34d Pending Nov 23, 2022
17983924 MULTILAYERED META LENS AND OPTICAL APPARATUS INCLUDING THE SAME SANZ, GABRIEL A 2872 §103 Non-Final OA 9d overdue Pending Nov 09, 2022
18049724 COMPLEXES FOR GENE DELETION AND EDITING LEONARD, ARTHUR S 1631 §103 Final Rejection 11d overdue Pending Oct 26, 2022
17921027 IMPROVED CAS 12A/NLS MEDIATED THERAPEUTIC GENE EDITING PLATFORMS KONOPKA, CATHERINE ANNE 1635 §103 Non-Final OA 16d overdue Pending Oct 24, 2022
17913100 MICRORNAS FOR THE PREVENTION OF CLINICAL VENOUS THROMBOEMBOLIC DISEASE WHITEMAN, BRIAN A 1636 §103 Non-Final OA 8d Pending Sep 20, 2022
17796184 A CAS9-PDBD BASE EDITOR PLATFORM WITH IMPROVED TARGETING RANGE AND SPECIFICITY EPSTEIN, TODD MATTHEW 1652 §112 Non-Final OA Pending Jul 28, 2022
17812332 INTRAUTERINE DEVICE (IUD) HAN, ROBIN 3786 §103Other Final Rejection 49d overdue Pending Jul 13, 2022
17779505 NOVEL AAV3B VARIANTS THAT TARGET HUMAN HEPATOCYTES IN THE LIVER OF HUMANIZED MICE VIJAYARAGHAVAN, JAGAMYA NMN 1633 §112 Final Rejection 27d Pending May 24, 2022
17777363 COMPOSITIONS AND METHODS FOR OPTOGENETIC IMMUNOTHERAPY SUNSHINE, HANNAH LOUISE 1647 §102§103 Non-Final OA 5d overdue Pending May 17, 2022
17730369 SYSTEM AND METHODS FOR EVALUATING IMAGES AND OTHER SUBJECTS BIBBEE, CHAYCE R 2624 §102§103 Final Rejection Pending Apr 27, 2022
17760504 TARGETING RLIM TO MODULATE BODY WEIGHT AND OBESITY TRAN, CHRISTINA L 1637 §112 Non-Final OA Pending Mar 15, 2022
17634586 DIAGNOSTIC TEST FOR IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS CESARE, JOSEPH DAVID 1675 §101§112 Final Rejection Pending Feb 11, 2022
17532636 OLIGONUCLEOTIDES FOR DGAT2 MODULATION ARIETI, RUTH SOPHIA 1635 §103Other Non-Final OA 2d overdue Pending Nov 22, 2021
17608890 IRF2 AS A PROGNOSTIC BIOMARKER AND TARGET FOR AUGMENTING IMMUNOTHERAPY PATTERSON, SARAH COOPER 1675 §103 Final Rejection Pending Nov 04, 2021
17358481 DEEP-LEARNING BASED CERTAINTY QUALIFICATION IN DIAGNOSTIC REPORTS DAY, ROBERT N 2122 §101§103 Final Rejection Pending Jun 25, 2021
17318846 MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING ZARA, JANE J 1637 §112 Final Rejection Pending May 12, 2021
16999759 O-METHYL RICH FULLY STABILIZED OLIGONUCLEOTIDES ARIETI, RUTH SOPHIA 1635 §103DPOther Non-Final OA Pending Aug 21, 2020
16762003 Post-Operative Hybrid Dressing To Optimize Skin-Grafting Procedures In Reconstructive Surgery HAN, SETH 3781 §103§112 Final Rejection 28d overdue Pending May 06, 2020
18134785 LOW-K AND LOW DIELECTRIC LOSS DIELECTRIC COMPOSITION FOR AEROSOL JET PRINTING TALBOT, BRIAN K 1764 §103§112 Non-Final OA Pending Apr 14, 2023
17186940 Lane-Level Route Planner for Autonomous Vehicles ALSOMAIRY, IBRAHIM ABDOALATIF 3667 §103 Final Rejection Pending Feb 26, 2021

Managing University of Massachusetts's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month